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ABSTRACT
EDEN-BP (embryo deadenylation element-binding
protein) binds speci®cally to the EDEN motif in the
3¢-untranslated regions of maternal mRNAs and
targets these mRNAs for deadenylation and transla-
tional repression in Xenopus laevis embryos. EDEN-
BP contains three RNA recognition motifs (RRMs)
and is related to the elav family of RNA-binding
proteins. In the present study we show that the two
N-terminal RRMs of EDEN-BP are necessary for the
interaction with EDEN as well as a part of the linker
region (between RRM2 and RRM3). Using a band
shift assay we show that two different complexes
are formed according to the size and, therefore, the
functional nature of the EDEN motif. Finally, we
show that EDEN-BP can form a dimer in a two-
hybrid assay. Accordingly, we suggest that the
functional con®guration of EDEN-BP is a dimer.
INTRODUCTION
In most species transcription is silent during the ®rst hours of
embryonic development. Accordingly, during this period the
post-transcriptional regulation of gene expression is especially
important. A number of studies have shown that the recruit-
ment or release of many maternal mRNAs into or from the
polysomes is correlated, respectively, with the lengthening or
shortening of the poly(A) tail (reviewed in 1).
Several RNA elements that control poly(A) tail length have
been identi®ed, both in somatic cells and in the oocytes and
embryos of several species. In Xenopus the cytoplasmic
polyadenylation element (CPE) (2,3) or in the mouse the
adenylation control element (ACE) (4) is required for
polyadenylation and polysome recruitment during oocyte
maturation. The CPE is also involved in translational regula-
tion of mRNA in neurones (5,6). The AU-rich element (ARE)
promotes the rapid deadenylation of many short-lived mRNAs
in somatic cells (7,8) and in Xenopus embryos (9,10). The
embryo deadenylation element (EDEN) confers a deadenyla-
tion behaviour on host RNAs in Xenopus embryos (11,12) and
probably in somatic cells (13). This element acts as a
translational repressor in Drosophila oocytes and in
Drosophila and Xenopus embryos (13,14). The trans-acting
factor, EDEN-binding protein (EDEN-BP), that binds to this
motif has been identi®ed (15) and cloned (12). EDEN-BP is a
53 kDa protein necessary for the EDEN-dependent de-
adenylation process in Xenopus embryo cell-free extracts (12).
EDEN-BP contains three RNA recognition motifs (RRMs)
(16±18). The most highly conserved motifs in these 80±90
amino acid domains are the ribonucleoprotein 1 and 2 (RNP1
and RNP2) sequences, which have been shown to interact
directly and speci®cally with RNA (19±21). The disposition of
the three RRMs in EDEN-BP is similar to that found in RNA-
binding proteins of the elav family, i.e. two consecutive RRMs
(RRM1 and RRM2) situated in the N-terminal region followed
by a linker region and the third RRM (RRM3) close to the
C-terminus of the protein. Recently, Good et al. (22) identi®ed
a phylogenetically related sub-population of the elav-related
proteins. This is the family of bruno-related RNA-binding
proteins that includes EDEN-BP, also named Xenopus laevis
bruno-like protein-2 (Xl BruL 2).
Within the framework of our ongoing programme to
characterise the functionally active EDEN-BP complex we
have determined the domains of this protein that are required
for EDEN-speci®c binding. This data highlighted a need for a
portion of the linker region, suggesting dimerisation of EDEN-
BP on the cognate RNA. To substantiate this hypothesis we
show that the number of U/purine repeats affects the
electrophoretic mobility of the RNA±protein complex and
that EDEN-BP can form a dimer in a yeast two-hybrid assay.
We propose that EDEN-BP is a dimer in the deadenylation-
pro®cient complex targeted by the EDEN motif.
MATERIALS AND METHODS
Cloning of recombinant proteins
The plasmid vectors expressing full-length EDEN-BP (protein
F) and the deletion mutants (proteins A±E, 3 and 5) were
constructed by PCR ampli®cation of the appropriate regions of
EDEN-BP cDNA (12). Pfu polymerase and the oligonucle-
otide primers listed below were used. After denaturation for
1 min at 94°C, the primers were annealed for 1 min at the
following temperatures: E, 43°C; B±D and 5, 57°C; A and 3,
67°C; F, 74°C. Thirty elongation cycles were performed for
100 s at 72°C. To add an adenosine residue at each 3¢
extremity the PCR products were incubated for 30 min at 72°C
in the presence of Taq polymerase. Each PCR product was
cloned in the PinPoint Xa 1-T vector (Promega). All the
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plasmid constructions were con®rmed by sequencing of the
complete open reading frames (ORFs).
The PCR primers were designed to add a histidine tag at the
C-terminus of the recombinant proteins and to place the
N-terminal extremity of the recombinant proteins in-frame
with the biotinylable peptide encoded by the vector. The
forward primer for A±F was 5¢-TAA TGG CAC AAT GGA
CCA CCC AGA CCA T-3¢. The reverse primers were: A, 5¢-
TTA GTG ATG GTG ATG GTG ATG ACT AGT GAA AGT
AAT AAA ACA GCA TCC-3¢; B, 5¢-TTA GTG ATG GTG
ATG GTG ATG ACT AGT CGT AAC GAA TGC ACA TCC-
3¢; C, 5¢-TTA GTG ATG GTG ATG GTG ATG ACT AGT
CCC AGA GGA GGC GGT CTG-3¢; D, 5¢-TTA GTG ATG
GTG ATG GTG ATG ACT AGT AGC TCC TAG GGA TGC
CAT-3¢; E, 5¢-TTA GTG ATG GTG ATG GTG ATG ACT
AGT GTT GGC TCC TTC TGG GCC-3¢; F, 5¢-TTA GTG
ATG GTG ATG GTG ATG TAC GTA GGG TTT GCT GTC
ATT-3¢. The forward primer used to clone N-terminal deletion
mutants of EDEN-BP (proteins 3 and 5) was 5¢-TTA GTG
ATG GTG ATG GTG ATG TAC GTA GGG TTT GCT GTC
ATT-3¢. The reverse primers were: 3, 5¢-GGG GGC TAG
CAA CCT CAA CTC CCT AAG T-3¢; 5, 5¢-GGG GGC TAG
CTA CAC AAG AAA AGC TGC G-3¢.
Expression and puri®cation of mutant EDEN-BP
Bacteria (Sure; Stratagene) were transformed with the differ-
ent EDEN-BP-derived constructs. Cells were grown in LB
medium containing ampicillin (200 mg/ml) at 37°C to an A600
of 0.4, induced with isopropyl-b-D-thiogalactopyranoside
(5 mM) and harvested 2 h later. The cells were suspended in
10 mM HEPES (pH 7.5), 300 mM NaCl, 50 mM sucrose,
10 mM imidazole, 1% Triton X-100 and protease inhibitors
(leupeptin, chymostatin and pepstatin at 0.1 mg/ml ®nal
concentration), lysed by sonication and centrifuged for 30 min
at 14 600 g. The supernatant was loaded onto a HiTrap
chelating column (Pharmacia) activated with nickel cations.
The nickel columns were washed with 50 ml of loading buffer
(lysis buffer without Triton X-100). Bound proteins were
eluted with an imidazole concentration gradient from 0 to
500 mM and collected on ice. Each fraction was conserved at
±20°C with glycerol (50%), BSA (10 mg/ml ®nal) and protease
inhibitors (leupeptin, pepstatin and chymostatin at 0.1 mg/ml
each). The quality and quantity of the recombinant proteins
were veri®ed by 12% SDS±PAGE and Coomassie blue
staining.
Xenopus egg extracts
Egg extracts were prepared essentially as described by Murray
and Kirschner (23) using versilube F-50 oil (General Electric)
to remove the buffer solution before crushing the biological
material by centrifugation. The cytosol layer was clari®ed by a
further centrifugation at 10 000 g for 15 min and stored at
±70°C.
RNA synthesis
The transcription template used to obtain the RNA containing
the c-mos EDEN used in the UV-induced label transfer assays
was generated by PCR using the oligonucleotides
T7EDENmos (5¢-GCGTAATACG ACTCACTATA GGG-
CGATATA TGTATGTGTT GTTT-3¢) and SP6EDENmos
(5¢-GCGATTTAGG TGACACTATA GAATACAGCA
CACACACACA CATA-3¢) and the plasmid pGbORF/
mosEDEN (12) as PCR template. The PCR product contains
both T7 and SP6 promoters that allow the synthesis of c-mos
EDEN RNA and antisense c-mos EDEN RNA, respectively.
Oligonucleotide transcription templates were used to synthe-
sise the RNAs used in the RNA gel shift assay [N36, N14-
(UGUA)4-N14, N14-(UGUA)9-N14 c-mos, Eg5 and Eg5S3].
They were produced by hybridising an oligonucleotide
containing the T7 promoter sequence (T7pr) with an
oligonucleotide containing the sequence to be transcribed
(24). The oligonucleotides T7pr, Eg5 and Eg5S3 have been
described previously (12). The other oligonucleotide
sequences were as follows: N36, 5¢-(N)36CTATAGTGAG-
3¢; (UGUA)4, 5¢-(N)10(TACA)4(N)10CTATAGTGAG-3¢;
(UGUA)9, 5¢-(TACA)9CTATAGTGAG-3¢; MOS, 5¢-AGAA-
GAGCAC ACACACACAC ATAAAACAAC ACATA-
CATAT AAAACACTCT ATAGTGAG-3¢. Brie¯y, the oligo-
nucleotide T7pr was phosphorylated and hybridised to a
template oligonucleotide. Then, the oligonucleotides were
ligated, phenol extracted, precipitated and used as transcrip-
tion templates.
32P-labelled uncapped transcripts were made in vitro with
the Promega Riboprobe transcription kit as previously
described (15). The RNAs were phenol/chloroform extracted
and ethanol precipitated.
UV-induced label transfer and western blot analyses
For UV-induced label transfer or UV crosslinking, egg
extracts were diluted 10-fold in reaction buffer (10 mM
HEPES pH 7.5, 1 mM MgCl2, 0.1 mM CaCl2 and 100 mM
KCl) as described previously (15) with the addition of heparin
(10 mg/ml), tRNA (1 mg/ml) and dithiothreitol (5 mM). The
different puri®ed recombinant proteins (~40 ng/sample) were
incubated under the same conditions.
32P-labelled RNAs (50 fmol) containing the c-mos EDEN
RNA motif or antisense EDEN motif were added to these
reaction solutions, which were processed for UV-induced
label transfer as previously described (15). The radiolabelled
proteins were separated by electrophoresis on 12% denaturing
polyacrylamide gels. After migration, the gels were trans-
ferred to nitrocellulose membranes. Western analysis was
performed using anti EDEN-BP antibodies (12) and revealed
with anti-rabbit alkaline phosphatase antibody (1/30 000;
Sigma) and NBT/BCIP reagent. The membranes were then
exposed for autoradiography.
RNA gel shift
Aliquots of 100 fmol in vitro synthesised, radiolabelled RNA
were incubated at 25°C for 30 min in XB buffer (10 mM
HEPES±KOH pH 7, 100 mM KCl, 1 mM MgCl2, 0.1 mM
CaCl2) with energy mix (7.5 mM creatine phosphate, 1 mM
ATP, 1 mM MgCl2, 0.1 mM EGTA, pH 7.7), 5 mM DTT,
4 U/ml RNAsin, 10 mg/ml heparin, 5 mg/ml yeast tRNA with
or without 0.5 ml of 4 h post-fertilisation embryo extract.
Samples were resolved on a 5% polyacrylamide gel
(acrylylamide/bisacrylamide 60:1) in 0.253 TBE. The gel
was dried and autoradiographed.
In coupled UV-induced label transfer/RNA gel shift
experiments the gel shift samples were UV irradiated before
resolution on a native polyacrylamide gel. After electro-
phoresis the RNA±protein complexes were localised by
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autoradiography of the wet gel and the appropriate regions
excised. The gel slabs were soaked for 30 min at 20°C in a
RNase A solution (5 mg/ml) in 10 mM Tris±HCl pH 8, 1 mM
EDTA and then inserted into the wells of a denaturing
SDS±polyacrylamide gel. After electrophoresis the gel was
dried and autoradiographed.
Yeast two-hybrid assay
pAD/IRP, a plasmid expressing the rabbit iron regulatory
protein fused to the Gal4 activation domain was a gift from
M. Wickens (University of Madison, Madison, WI) (25); the
parent vector was pACT2. pGBT9/EDEN-BP was produced
by subcloning the entire ORF of EDEN-BP (12) into the
EcoRI and SalI sites of pGBT9. pAD/EDEN-BP was produced
by subcloning the EDEN-BP ORF, isolated from pGBT9/
EDEN-BP by restriction digestion of this plasmid with EcoRI
followed by Klenow treatment and a second digestion with
SalI. The insert was subcloned into the pACT2 vector ®rst
digested with XmaI and Klenow treated and then digested with
XhoI. Sequences were con®rmed by sequencing. Cells of the
strain HF7c [MATa ura3-52 his3-200 ade2-101 lys2-801 trp1-
901 leu2-3,112 gal4-542 gal80-538 LYS2::GAL1-HIS3
URA3::(GAL4 17mers)3-CYC1-lacZ] (26) were transformed
with pGBT9/EDEN-BP. Transformants were selected and
transformed with pAD/IRP or pAD/EDEN-BP. Cells bearing
both pGBT9/EDEN-BP and pAD/IRP or pGBT9/EDEN-BP
and pAD/EDEN-BP were selected on medium lacking leucine
and tryptophan. Individual clones were picked and analysed
for their ability to activate His3 expression in the presence of
several concentrations of 3-aminotriazole (3-AT) at 30°C.
Plates were photographed.
RESULTS
Domain mapping of EDEN-BP shows sequence-speci®c
binding
To map the region of EDEN-BP that is required for sequence-
speci®c binding to the RNA motif EDEN, the complete
reading frame and ®ve recombinant proteins with C-terminal
deletions and two recombinant proteins with N-terminal
deletions (Fig. 1A) were produced in bacteria. These proteins
were obtained by cloning the appropriate PCR products in the
PinPoint Xa 1-T vector as described in Materials and Methods.
The C-terminal deletions consist of consecutive 83±88 amino
acid deletions without separating the RNP1/RNP2 motifs of
any RRM (see Fig. 1A). The N-terminal deleted recombinant
proteins (proteins 3 and 5 in Fig. 1A) contained, respectively,
amino acids 238±489 and 65±489 of EDEN-BP. All of these
proteins possess a biotinylable tag (13 kDa) at the N-terminal
extremity and a His6 tag (0.84 kDa) at the C-terminus
(Fig. 1A).
Speci®c binding of these recombinant proteins to the EDEN
motif was analysed by UV-induced label transfer. The puri®ed
recombinant proteins were incubated with [32P]UTP-labelled
in vitro transcripts containing either the c-mos EDEN or the
antisense RNA sequence and processed for UV-induced label
transfer analysis as described in Materials and Methods.
During puri®cation of the recombinant proteins we
observed that they were relatively unstable and were rapidly
degraded in certain preparations. Addition of carrier protein,
such as BSA, to the puri®ed protein did not systematically
alleviate this problem. Therefore, in all the experiments
described here the integrity of the proteins after UV-induced
label transfer was veri®ed by western blotting. After separ-
ation by SDS±PAGE the UV-irradiated proteins were trans-
ferred to nitrocellulose membrane and revealed with anti-
EDEN-BP antibodies (Fig. 1C). The membrane was then
exposed for autoradiography (Fig. 1B). As a control, the
signals obtained with the recombinant proteins (Fig. 1B, lanes
3±18) were compared with that produced by maternal Xenopus
EDEN-BP present in activated egg extracts (Fig. 1B, lanes 1
and 2).
As expected, the maternal EDEN-BP only produced a UV-
induced radiolabelling signal with the sense EDEN motif
(Fig. 1B, compare lanes 1 and 2). The full-length recombinant
protein F (Fig. 1B, lanes 3 and 4) showed the same pattern of
the UV-induced radiolabelling signal. The western blot data
(Fig. 1C) con®rm that the absence of UV-induced radiolabel-
ling signal for the maternal EDEN-BP or recombinant protein
F incubated with the antisense EDEN transcript was not due to
an absence of protein.
Protein E, from which essentially all of RRM3 is deleted,
still binds speci®cally to the EDEN motif (Fig. 1B, lanes 5 and
6). Sequence-speci®c binding was also retained in protein D
(lanes 7 and 8), from which ~80 amino acids of the 251 amino
acid linker region had been removed. However, further
shortening of the recombinant proteins (proteins A±C) abro-
gated RNA binding (Fig. 1B, lanes 9±14). Neither of the
N-terminal deleted proteins (proteins 3 and 5) produced a
radiolabelled product with either the sense or the antisense
EDEN (Fig. 1B, lanes 15±18).
The western blot data obtained using EDEN-speci®c
antibodies (Fig. 1C) shows that the lack of radioactive product
for proteins A±C, 3 and 5 was due to a loss of RNA binding
and not to a degradation of the recombinant proteins during the
UV-induced label transfer.
The epitopes of the anti-EDEN-BP polyclonal antibodies
used for these western analyses are not known. Therefore, it is
not possible to make a quantitative comparison between the
recombinant proteins. Indeed, these antibodies produced only
a weak signal for proteins A and B (see Fig. 1C, lanes 11±14),
whereas Coomassie Blue staining of these same samples on a
parallel SDS±PAGE (data not shown) showed that the amount
of recombinant protein in these samples was greater than that
for the other proteins analysed in this experiment.
Therefore these data show that binding to the c-mos EDEN
requires both of the N-terminal RRM of EDEN-BP and a
major part of the linker region.
RNA gel shift analysis of EDEN-BP binding
We have previously shown that contiguous UGUA repeats can
constitute a functional synthetic EDEN so long as they contain
a suf®cient number of repetitions (27). Four (16 nt) and six
(24 nt) repeats were ineffective in conferring deadenylation on
a RNA; nine repetitions (36 nt) conferred ef®cient de-
adenylation. Furthermore, the two fully characterised natural
EDENs (those of the Eg5 and c-mos mRNA) clearly contain
two distinct U/purine domains (see Fig. 2A). However, the
crystal structure of the RNA-binding domains of HuD and
sexlethal with their associated RNA show that the two tandem
RRMs of these proteins only occupy 11 and 12 nt, respectively
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(28,29). These considerations, in addition to the need for a
portion of the linker region in the binding experiments,
suggested that EDEN-BP might form a dimer when active. If
this were the case then the size of the EDEN-BP/EDEN
complex should depend on the length of the sequence to which
EDEN-BP is bound.
Accordingly, band shift experiments were performed using
cell-free embryo extracts and radiolabelled RNAs corres-
ponding to synthetic EDENs of different size as well as the
c-mos- and Eg5-derived EDENs (Fig. 2A). In order to be able
to directly compare the size of the complexes formed, all the
RNAs contained approximately the same number of nucle-
otides. We have previously shown that UV-induced label
transfer using Eg5 and c-mos EDEN gives a unique radio-
active signal, that of EDEN-BP (12).
The results of the band shift experiment given in Figure 2B
show that the c-mos EDEN (lanes 7 and 8) forms a unique
complex (U) when incubated in cytoplasmic embryo extracts.
The functional synthetic EDEN, (UGUA)9, forms a complex
of identical size (lanes 5 and 6). The shorter non-functional
synthetic EDEN, (UGUA)4 (lanes 3 and 4), produces a faster
moving complex (L). Both complexes U and L are observed
with the Eg5-derived EDEN.
To con®rm that these complexes contain EDEN-BP,
coupled UV-induced label transfer/RNA gel shift experiments
were performed using Eg5, as this RNA produced both
complexes U and L in the RNA gel shift assay. As shown in
Figure 2C (lane 1), UV irradiation of embryo extracts
containing 32P-labelled Eg5 RNA yielded a single radioactive
protein at 53 kDa. This protein, which was previously
identi®ed as EDEN-BP (12), was absent when the Eg5S3
RNA was used (Fig. 2C, lane 2). The Eg5S3 RNA contains a
mutation in the EDEN motif that abrogates EDEN-BP binding
(12). For the coupled UV-induced label transfer/RNA gel shift
experiments the embryo extracts containing the 32P-labelled
Eg5 RNA were UV irradiated prior to separation on a native
Figure 1. Analysis of the RNA binding speci®city of full-length, N-terminal and C-terminal deletion mutants of EDEN-BP. (A) Schematic representation of
mutant recombinant EDEN-BP. All constructs were tagged at the N-terminus with a biotinylable peptide (Bio-Pep) and at the C-terminus with a histidine tag
(63His). For simplicity these tags are only shown for protein F. The predicted molecular weight and name of each of these tagged proteins are indicated on
the right. The positions of the RRMs are indicated (R1, R2 and R3) above the schematic proteins as well as the number of the boundary amino acids relative
to the wild-type protein without the biotinylable peptide. The individual RNP motifs are represented by dark boxes. (B) UV-induced label transfer of the
recombinant proteins and wild-type EDEN-BP to RNA containing (+) or devoid of (±) the EDEN motif. After irradiation with UV light and treatment with
RNase A, the proteins were resolved by electrophoresis in the presence of SDS. Proteins were transferred to nitrocellulose membranes and the radiolabelled
proteins were revealed by autoradiography. The asterisk indicates the position of the radioactive signal. (C) The same membranes were probed with puri®ed
anti-EDEN-BP antibodies. Lane indications and numbers are as for (B). The positions of the molecular weight markers (kDa) are indicated on the left of each
panel. The asterisk indicates the position of the recombinant EDEN-BP protein.
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polyacrylamide gel (Fig. 2C, lane 5). This treatment did not
modify migration of the RNA±protein complexes (data not
shown). In these experiments the separation of the
protein±RNA complexes (Fig. 2C, lane 5) was less apparent,
for technical reasons, than that shown in Figure 2B (lane 10).
First, more radioactivity had to be loaded in order to retain a
detectable signal after the second electrophoretic separation
and, secondly, autoradiography of the wet gel led to a loss of
resolution. Irrespective of this loss of separation the RNA
probe is clearly shifted to an extended region similar to that
covered by complexes U and L (Fig. 2B, lane 10). Bands
corresponding to the upper (U) and lower (L) parts of this
extended region were excised and treated as described in
Materials and Methods. The data given in Figure 2C (lanes 3
and 4) show that protein±RNA complexes within both parts of
this extended region contained a radiolabelled protein that co-
migrated with EDEN-BP.
In contrast to the c-mos EDEN, the two parts of the
Eg5-derived EDEN are not comparable in U/purine richness
(see Fig. 2A). The c-mos EDEN contains two blocks of six and
eight U/purine repeats whereas the Eg5 EDEN has a 5¢ section
of seven U/purine repeats and a 3¢ section with only four
U/purine repeats. We interpret the RNA gel shift data as
indicating that the (UGUA)4 RNA binds one molecule of
EDEN-BP to give the lower complex L. When the EDEN is
lengthened to (UGUA)9, two EDEN-BP molecules can
associate with the same RNA to give complex U. This
complex is also observed with the c-mos EDEN, that is similar
in size to the (UGUA)9 RNA (Fig. 2B). We propose that the
unbalanced nature of the Eg5 EDEN leads to the formation of
both complex U (dimer) and L (monomer). As (UGUA)4 is
not functional whereas the (UGUA)9 EDEN is capable of
conferring a deadenylation behaviour this interpretation
implies that the functional form of EDEN-BP is a dimer.
EDEN-BP can dimerise in a two-hybrid assay
In order to determine whether EDEN-BP can form a dimer, a
two-hybrid screen protocol was set up. Two-hybrid analysis
allows the strength of a protein±protein interaction to be
assessed by the reconstitution of a bipartite transcription
factor. This bipartite transcription factor is formed by two
proteins: one is a fusion between the ®rst protein to be tested
and the GAL4 DNA-binding domain; the second protein is
composed of the other protein to be tested (here EDEN-BP)
fused to the GAL4 activation domain. When the two tested
proteins interact, a functional transcription factor is formed
and the activity of reporter gene (HIS3) can be determined by
its capacity to permit growth of yeast cells on medium lacking
histidine. The strength of the interaction can be evaluated by
adding 3-AT, a competitive inhibitor of the HIS3 gene. The
concentration of 3-AT still allowing growth of the yeast cells
is an indication of the strength of the interaction.
HF7c yeast cells expressing the DNA-binding domain/
EDEN-BP fusion protein (pGBT9/EDEN-BP) were trans-
formed with either the activating domain/EDEN-BP fusion
protein (pAD/EDEN-BP) or the activating domain/iron
Figure 2. Analysis of the EDEN-BP/UGUA repeat complex. (A) Sequence of the RNA molecules. U/purine dinucleotides are in bold. The minimal c-mos
EDEN that is ef®cient in deadenylation is underlined. (B) RNA gel shift analysis. The indicated radiolabelled RNAs were incubated with (+) or without (±)
4 h post-fertilisation embryo extract. The complexes formed were analysed by native PAGE. The position of the free probes are indicated as well as the
position of the two complexes formed: Upper (U) and Lower (L). (C) Coupled UV-induced label transfer and RNA gel shift. Lanes 1 and 2, UV-induced
label transfer analysis of Eg5 and the mutant Eg5S3 RNAs incubated in embryo extracts. Lanes 3 and 4, gel slabs corresponding to the positions of arrows U
and L in lane 5 were excised, treated with RNase A and deposited as indicated in the wells of a denaturing SDS±polyacrylamide gel. After electrophoresis the
gel was dried and the radiolabelled proteins revealed by autoradiography. Lane 5, The Eg5 RNA was incubated in embryo extracts and UV irradiated prior to
separation of the protein±RNA complexes on a native polyacrylamide gel and autoradiography of the un®xed wet gel. At the bottom of the ®gure, D indicates
denaturing gel and N indicates native gel.
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regulatory fusion protein (pAD/IRP) as a control. When plated
on agar plates lacking leucine and tryptophan to select for the
presence of both plasmids PGBT9/EDENBP and pAD/EDEN-
BP or pAD/IRP, both sets of yeast cells grew (Fig. 3, ±LW). In
the absence of histidine, leucine and tryptophan (±HLW),
which tests for transcriptional activation of the HIS3 gene,
growth was detected only for the yeast cells expressing both
forms of the EDEN-BP fusion protein. This indicates that the
two EDEN-BP-containing fusion proteins interact. In order to
assess the strength of this interaction cells were plated on
medium containing increasing concentrations of 3-AT.
Growth was still observed with 10 mM 3-AT, indicating a
robust interaction between the two EDEN-BP-containing
proteins. Growth was lost at 20 mM 3-AT.
DISCUSSION
We report here experiments demonstrating that sequence-
speci®c binding of the Xenopus protein EDEN-BP requires the
two N-terminal RRMs and at least the ®rst 167 amino acids of
the linker region. This need for a portion of the linker,
combined with the previous observation that a 16 nt U/purine
repeat was insuf®cient to constitute a functional EDEN (27)
and that an 11 or 12 nt RNA is associated, respectively, with
the two tandem RRMs of HuD and sexlethal (28,29),
suggested that the active con®guration of EDEN-BP may be
a dimer. In agreement with this hypothesis we observed, using
a RNA gel shift assay, that two complexes are formed on
U/purine repeats of different size; functional EDENs [c-mos,
Eg5 and (UGUA)9] produce a complex with a reduced
electrophoretic mobility when compared to the complex
formed on the short (non-functional) U/purine repeats.
Lastly, EDEN-BP was shown to form a dimer in a two-hybrid
assay.
We interpret the two complexes formed in the gel shift
assay as representing monomers and dimers of the full-length
EDEN-BP. This would appear to be incompatible with the
initial hypothesis that the loss of UV-induced label transfer,
for proteins shortened 5¢ to amino acid 320, may be due to the
inability of these proteins to form dimers. However, these two
experimental approaches do not probe the same structural
features of the RNA±protein complex. In the UV-induced
label transfer the RNA is of optimum length (c-mos EDEN)
and the proteins are of variable size. In contrast, in the gel shift
assay the protein contains its full complement of RRMs and
the RNAs are of variable length. Maintenance of the EDEN-
BP monomer on the (UGUA)4 and Eg5 RNAs could be due to
non-speci®c binding of the protein to the RNA, for instance
via RRM3, such that the binding of the monomer is
suf®ciently reinforced to allow it to be visualised in the
denaturing gel. This non-speci®c binding would be min-
imalised with the C-terminal deleted proteins.
EDEN-BP has the same overall organisation as the RNA-
binding proteins of the elav family. A number of the human
and mouse Hu RNA-BPs, which are related to elav by
sequence homology, have been analysed with respect to the
role of the different RRMs in RNA binding. In most cases,
speci®c RNA binding required RRM1 and all or part of RRM2
(30±33). Evidence has also been reported that RRM1 is mainly
responsible for binding and RRM2 enhances the interaction
(30,31). This functional pattern for the different RRMs in the
Hu family of elav-related proteins is compatible with the
results described here for EDEN-BP.
Recently, Good et al. (22) identi®ed by sequence compari-
son a family of RNA-binding proteins, of which EDEN-BP is
a member, that are more closely related to the Drosophila
protein bruno than to the Hu elav-related proteins. The binding
speci®city of the RRMs for several of these proteins has been
reported. Binding of the Drosophila protein bruno (49%
identity with EDEN-BP in the overlapping region) to the
bruno response element was observed for a fragment contain-
ing RRM3 and the distal half of the linker (34). For the human
CUG-BP, which is more closely related to EDEN-BP (87%
identity), Timchenko et al. (35) reported that RRM1 and
RRM2 were necessary and suf®cient for binding to a (CUG)8
motif. Using a three-hybrid assay, Takahashi et al. (36)
showed that this same protein bound much more strongly to
UG than to CUG repeats. RRM1 and RRM3 were dispensable
for binding to the RNA containing 36 UG repeats. The binding
to this RNA was partially reduced by deleting RRM2 and most
seriously affected by deleting the linker region. The Zebra®sh
protein Brul, which is 81% identical to EDEN-BP, also shows
a preference for UG-rich RNAs (37). However, using a RNA
containing eight contiguous U/purine dinucleotides these
authors observed that RRM1 and RRM2 together or RRM3
alone could bind speci®cally to this RNA.
The divergence between the previously published results for
bruno, CUG-BP and Brul and the data reported here for
EDEN-BP resides mainly in the role of the third RRM and the
linker region. There are several dissimilarities in these
experiments that could, individually or together, lead to the
observed differences.
First, only the UV-induced label transfer data reported for
bruno (34) and that reported here were obtained with a
naturally occurring sequence element. In addition, the other
RNAs are of insuf®cient length to allow the formation of a
dimer. This may possibly explain why a dependence on the
linker region was not observed in other studies with the
exception of the three-hybrid analysis (36).
Secondly, the cDNA used to produce the recombinant
EDEN-BP was of maternal origin (12) whereas CUG-BP was
cloned from human adult tissue cDNA libraries (38) and Brul
was cloned from a 20±28 h post-fertilisation Zebra®sh library
Figure 3. EDEN-BP dimerises in a yeast two-hybrid assay. HF7c cells that
had been transformed by pGBT9/EDEN-BP (DNA-binding domain/EDEN-
BP fusion protein) were subsequently transformed with either pAD/EDEN-
BP (activating domain/EDEN-BP fusion protein) or pAD/IRP (activating
domain/iron regulatory fusion protein) as indicated at the top of the ®gure.
Serial dilutions (1/10) of individual clones were replica plated on the
indicated medium (±LW, medium lacking leucine and tryptophan; ±HLW,
medium lacking histidine, leucine and tryptophan). When used, the concen-
tration of 3-AT was as indicated (5, 10 and 20 mM).
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(39). We have identi®ed several isoforms of EDEN-BP in
Xenopus embryos that show different patterns of expression
during development (Y. Audic, unpublished data). Therefore,
the cloned Brul cDNA may well correspond to a zygotic rather
than a maternal isoform.
Although these proteins show almost identical binding
speci®city in vitro, their function may be different in vivo.
Indeed, we have shown that EDEN-BP is a deadenylation
speci®city factor (12) whereas the only identi®ed functions for
CUG-BP and Brul are in regulating splicing or translation
independently of the poly(A) tail (37,40±43). These differ-
ences in function could require different associations of the
RNA-binding protein with the target mRNA. Although bruno
is also of maternal origin and acts as a translational repressor
(44) it is only 49% identical to EDEN-BP in the overlapping
region and there is no evidence to date that it acts as a
deadenylation factor.
The human orthologue of EDEN-BP, the protein CUG-BP,
has been shown to be a phosphoprotein (45) and we have
evidence (L.Detivaud, G.Pascreau, H.B.Osborne and
J.Kubiak, submitted for publication) that EDEN-BP is also
phosphorylated. As the full-length recombinant protein
(protein F) used in the present study was expressed in bacteria
we can assume that phosphorylation is not required for
sequence-speci®c binding to the EDEN motif. These post-
translational modi®cations may, however, be important for the
transactivation of deadenylation by EDEN-BP.
We have previously shown that 8 or 12 U/purine repeats (16
or 24 nt) are ineffective in conferring deadenylation on a
reporter RNA whereas a 36 nt U/purine motif is much more
ef®cient (27). The proposed dimerisation of EDEN-BP could
explain this length effect of the EDEN motif. For instance, the
dimer may have a greater af®nity for the RNA element than
the sum of the individual af®nities. Alternatively, the EDEN-
BP dimer may form an interface that is required for interaction
with necessary cofactors. Eventually the association of the
EDEN-BP dimer with the RNA could induce a conformational
change in the protein that unmasks the interaction interface. A
precedent for such a scenario is the functional complex formed
by two U1A proteins and the cognate RNA (46). A
consequence of this dimer scenario is that the different
isoforms of EDEN-BP could form a variety of heterodimers. It
will be of interest to determine whether different heterodimers
favour one or the other of the processes in which the
homologues of EDEN-BP have been implicated.
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